Deka Bank Deutsche Girozentrale Glycomimetics Inc Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $61,039 - $280,130	-21,800 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$10.6 - $13.12 $89,040 - $110,208	8,400 Added 62.69%	21,800 $251,000
Q1 2019 May 10, 2019	BUY	$9.96 - $13.44 $24,900 - $33,600	2,500 Added 22.94%	13,400 $200,000
Q4 2018 Feb 12, 2019	SELL	$8.47 - $14.71 $21,175 - $36,775	-2,500 Reduced 18.66%	10,900 $95,000
Q3 2018 Nov 09, 2018	SELL	$13.7 - $17.12 $4,110 - $5,136	-300 Reduced 2.19%	13,400 $0
Q1 2018 May 03, 2018	BUY	$16.06 - $25.35 $220,021 - $347,295	13,700 New	13,700 $220,000

28.9M

51K

1.4K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.